Manufacturing woes prevent Astellas from a first-in-class drug approval

The latest stories trending on MedCity News.

Editor's Pick

Top Story Manufacturing Issues Block Astellas From a First-in-Class Cancer Drug Approval Astellas Pharma's zolbetuximab was on track to become the first gastric cancer drug that targets claudin 18.1, a protein found on cancerous stomach cells. Others with clinical-stage programs addressing this this target include AstraZeneca and Bristol Myers Squibb. Sponsored Content Chetu Delivers Custom Software Solutions for the Healthcare Industry Presented by Chetu Chetu is transforming healthcare with AI-driven solutions for greater efficiency and patient care. We provide custom healthcare software solutions & support services to the entire healthcare spectrum. Learn More.

Featured News

The Case for Asset Stewardship: How Healthcare Wastes Millions of Dollars on Endoscope Ownership U.S. healthcare is unnecessarily spending millions of dollars on scopes—dollars that could be better spent opening up new service lines, investing in medical equipment, or hiring nurses for improved patient care. Medical Innovation Must Shift Focus From Common Problems to Unsolvable Ones The innovator's mindset is shifting from solving the problems right in front of us to solving problems once considered impossible to fix. The lines between curable and incurable diseases are blurring in surgery because medical devices are scaling up precision and scaling down the size of anatomy that surgeons can operate on. Why One CEO Thinks Drugs Won't Be Able to Solve the Obesity Crisis New research found that there are no racial disparities in weight loss results among patients taking obesity drugs. However, the study found that people of color have less access to services like behavioral care or surgical interventions, which are often needed in order for patients to lose weight and keep it off. To tackle this issue, Enara Health CEO Rami Bailony argued that the U.S. healthcare system must innovate the way it dispenses weight loss drugs, employing a more holistic care approach.

Resources

Free eBook: "AI in Healthcare: Scratching the Surface" Learn how AI is transforming the healthcare industry and the pitfalls that also exist with its early adoption. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe